Oncology Biosimilar Market Size, Share, Growth Report 2032
Oncology Biosimilar Market By Cancer Type (Breast Cancer, Colorectal Cancer, Blood Cancer, Neutropenia Cancer, Non-Small Cell Lung Cancer, And Others), By Drug Type (MAb, Immunomodulators, Hematopoietic Agents, G-CSF, And Others), By Distribution Channel (Retail Pharmacies, Hospital Pharmacy, And Online Pharmacy), And By Region - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2024-2032
| Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 6.13 Billion | USD 28.26 Billion | 18.50% | 2023 |
Table Of Content
- Chapter 1. Introduction
- 1.1. Report description and scope
- 1.2. Research scope
- 1.3. Research methodology
- 1.3.1. Market research process
- 1.3.2. Market research methodology
- Chapter 2. Executive Summary
- 2.1. Global Oncology Biosimilar Market, 2024 - 2032 (USD Billion)
- 2.2. Global Oncology Biosimilar Market: Snapshot
- Chapter 3. Oncology Biosimilar Market Dynamics
- 3.1. Introduction
- 3.2. Market drivers
- 3.2.1. Global Oncology Biosimilar Market drivers: Impact analysis
- 3.2.2. increasing demand of affordable therapies due to the constant increase in cancer patients worldwide
- 3.3. Market Restraints
- 3.3.1. High cost associated with cancer treatment
- 3.3.2. Dearth of skilled personnel
- 3.4. Opportunities
- 3.4.1. Patent Expiry
- 3.5. Porter's five forces analysis
- 3.5.1. Bargaining power of suppliers
- 3.5.2. Bargaining power of buyers
- 3.5.3. Threat from new entrants
- 3.5.4. Threat from new substitutes
- 3.5.5. Degree of competition
- 3.6. Market attractiveness analysis
- 3.6.1. Market attractiveness analysis, by Test Type
- 3.6.2. Market attractiveness analysis, by Drug Type
- 3.6.3. Market attractiveness analysis, by Distribution Channel
- 3.6.4. Market attractiveness analysis, by Regional Segment
- Chapter 4. Global Oncology Biosimilar Market - Competitive Landscape
- 4.1. Company Market Share Analysis
- 4.1.1. Global Oncology Biosimilar Market: company market share, 2024
- 4.2. Strategic Development
- 4.2.1. Acquisitions & Mergers
- 4.2.2. New Test Type Launch
- 4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures
- 4.2.4. Research and Development, Regional Expansion
- 4.1. Company Market Share Analysis
- Chapter 5. Global Oncology Biosimilar Market - Test Type Segment Analysis
- 5.1. Global Oncology Biosimilar Market: Test Type overview
- 5.1.1. Global Oncology Biosimilar Market revenue share, by Test Type, 2024 and 2032(USD Billion)
- 5.2. Breast Cancer
- 5.2.1. Global Breast Cancer market, 2024 - 2032(USD Billion)
- 5.3. Colorectal Cancer
- 5.3.1. Global Colorectal Cancer market, 2024 - 2032(USD Billion)
- 5.4. Blood Cancer
- 5.4.1. Global Blood Cancer market, 2024 - 2032(USD Billion)
- 5.5. Neutropenia Cancer
- 5.5.1. Global Neutropenia Cancer market, 2024 - 2032(USD Billion)
- 5.6. Non-Small Cell Lung Cancer
- 5.6.1. Global Non-Small Cell Lung Cancer market, 2024 - 2032(USD Billion)
- 5.7. Others
- 5.7.1. Global Others market, 2024 - 2032(USD Billion)
- 5.1. Global Oncology Biosimilar Market: Test Type overview
- Chapter 6. Global Oncology Biosimilar Market - Drug Type Segment Analysis
- 6.1. Global Oncology Biosimilar Market: Drug Type overview
- 6.1.1. Global Oncology Biosimilar Market revenue share, by Drug Type, 2024 and 2032(USD Billion)
- 6.2. mAb
- 6.2.1. Global mAb market, 2024 - 2032(USD Billion)
- 6.3. Immunomodulators
- 6.3.1. Global Immunomodulators market, 2024 - 2032(USD Billion)
- 6.4. Hematopoietic Agents
- 6.4.1. Global Hematopoietic Agents market, 2024 - 2032(USD Billion)
- 6.5. G-CSF
- 6.5.1. Global G-CSF market, 2024 - 2032(USD Billion)
- 6.6. Others
- 6.6.1. Global Others market, 2024 - 2032(USD Billion)
- 6.1. Global Oncology Biosimilar Market: Drug Type overview
- Chapter 7. Global Oncology Biosimilar Market - Distribution Channel Segment Analysis
- 7.1. Global Oncology Biosimilar Market: Distribution Channel overview
- 7.1.1. Global Oncology Biosimilar Market revenue share, by Distribution Channel , 2014 and 2032(USD Billion)
- 7.2. Retail Pharmacies
- 7.2.1. Global Oncology Biosimilar Market for Retail Pharmacies, 2024 - 2032(USD Billion)
- 7.3. Hospital Pharmacy
- 7.3.1. Global Oncology Biosimilar Market for Hospital Pharmacy, 2024 - 2032(USD Billion)
- 7.4. Online Pharmacy
- 7.4.1. Global Oncology Biosimilar Market for Online Pharmacy, 2024 - 2032(USD Billion)
- 7.1. Global Oncology Biosimilar Market: Distribution Channel overview
- Chapter 8. Global Oncology Biosimilar Market - Regional Segment Analysis
- 8.1. Global Oncology Biosimilar Market: Regional overview
- 8.1.1. Global Oncology Biosimilar Market revenue share, by Region, 2024 and 2032
- 8.2. North America
- 8.2.1. North America Oncology Biosimilar Market revenue, by Test Type, 2024 - 2032(USD Billion)
- 8.2.2. North America Oncology Biosimilar Market revenue, by Drug Type, 2024 - 2032(USD Billion)
- 8.2.3. North America Oncology Biosimilar Market revenue, by Distribution Channel , 2024 - 2032(USD Billion)
- 8.2.4. North America Oncology Biosimilar Market revenue, by Region, 2024 - 2032(USD Billion)
- 8.2.5. U.S.
- 8.2.5.1. U.S. Oncology Biosimilar Market revenue, by Test Type, 2024 - 2032(USD Billion)
- 8.2.5.2. U.S. Oncology Biosimilar Market revenue, by Drug Type, 2024 - 2032(USD Billion)
- 8.2.5.3. U.S. Oncology Biosimilar Market revenue, by Distribution Channel , 2024 - 2032(USD Billion)
- 8.2.5.4. U.S. Oncology Biosimilar Market revenue, by Region, 2024 - 2032(USD Billion)
- 8.2.6. Rest of North America
- 8.2.6.1. Rest of North America Oncology Biosimilar Market revenue, by Test Type, 2024 - 2032(USD Billion)
- 8.2.6.2. Rest of North America Oncology Biosimilar Market revenue, by Drug Type, 2024 - 2032(USD Billion)
- 8.2.6.3. Rest of North America Oncology Biosimilar Market revenue, by Distribution Channel , 2024 - 2032(USD Billion)
- 8.2.6.4. Rest of North America Oncology Biosimilar Market revenue, by Region, 2024 - 2032(USD Billion)
- 8.3. Europe
- 8.3.1. Europe Oncology Biosimilar Market revenue, by Test Type, 2024 - 2032(USD Billion)
- 8.3.2. Europe Oncology Biosimilar Market revenue, by Drug Type, 2024 - 2032(USD Billion)
- 8.3.3. Europe Oncology Biosimilar Market revenue, by Distribution Channel , 2024 - 2032(USD Billion)
- 8.3.4. Europe Oncology Biosimilar Market revenue, by Region, 2024 - 2032(USD Billion)
- 8.3.5. Germany
- 8.3.5.1. Germany Oncology Biosimilar Market revenue, by Test Type, 2024 - 2032(USD Billion)
- 8.3.5.2. Germany Oncology Biosimilar Market revenue, by Drug Type, 2024 - 2032(USD Billion)
- 8.3.5.3. Germany Oncology Biosimilar Market revenue, by Distribution Channel , 2024 - 2032(USD Billion)
- 8.3.5.4. Germany Oncology Biosimilar Market revenue, by Region, 2024 - 2032(USD Billion)
- 8.3.6. U.K.
- 8.3.6.1. U.K. Oncology Biosimilar Market revenue, by Test Type, 2024 - 2032(USD Billion)
- 8.3.6.2. U.K. Oncology Biosimilar Market revenue, by Drug Type, 2024 - 2032(USD Billion)
- 8.3.6.3. U.K. Oncology Biosimilar Market revenue, by Distribution Channel , 2024 - 2032(USD Billion)
- 8.3.6.4. U.K. Oncology Biosimilar Market revenue, by Region, 2024 - 2032(USD Billion)
- 8.3.7. France
- 8.3.7.1. France Oncology Biosimilar Market revenue, by Test Type, 2024 - 2032(USD Billion)
- 8.3.7.2. France Oncology Biosimilar Market revenue, by Drug Type, 2024 - 2032(USD Billion)
- 8.3.7.3. France Oncology Biosimilar Market revenue, by Distribution Channel , 2024 - 2032(USD Billion)
- 8.3.7.4. France Oncology Biosimilar Market revenue, by Region, 2024 - 2032(USD Billion)
- 8.3.8. Rest of Europe
- 8.3.8.1. Rest of Europe Oncology Biosimilar Market revenue, by Test Type, 2024 - 2032(USD Billion)
- 8.3.8.2. Rest of Europe Oncology Biosimilar Market revenue, by Drug Type, 2024 - 2032(USD Billion)
- 8.3.8.3. Rest of Europe Oncology Biosimilar Market revenue, by Distribution Channel , 2024 - 2032(USD Billion)
- 8.3.8.4. Rest of Europe Oncology Biosimilar Market revenue, by Region, 2024 - 2032(USD Billion)
- 8.4. Asia Pacific
- 8.4.1. Asia Pacific Oncology Biosimilar Market revenue, by Test Type, 2024 - 2032(USD Billion)
- 8.4.2. Asia Pacific Oncology Biosimilar Market revenue, by Drug Type, 2024 - 2032(USD Billion)
- 8.4.3. Asia Pacific Oncology Biosimilar Market revenue, by Distribution Channel , 2024 - 2032(USD Billion)
- 8.4.4. Asia Pacific Oncology Biosimilar Market revenue, by Region, 2024 - 2032(USD Billion)
- 8.4.5. China
- 8.4.5.1. China Oncology Biosimilar Market revenue, by Test Type, 2024 - 2032(USD Billion)
- 8.4.5.2. China Oncology Biosimilar Market revenue, by Drug Type, 2024 - 2032(USD Billion)
- 8.4.5.3. China Oncology Biosimilar Market revenue, by Distribution Channel , 2024 - 2032(USD Billion)
- 8.4.5.4. China Oncology Biosimilar Market revenue, by Region, 2024 - 2032(USD Billion)
- 8.4.6. Japan
- 8.4.6.1. Japan Oncology Biosimilar Market revenue, by Test Type, 2024 - 2032(USD Billion)
- 8.4.6.2. Japan Oncology Biosimilar Market revenue, by Drug Type, 2024 - 2032(USD Billion)
- 8.4.6.3. Japan Oncology Biosimilar Market revenue, by Distribution Channel , 2024 - 2032(USD Billion)
- 8.4.6.4. Japan Oncology Biosimilar Market revenue, by region, 2024 - 2032(USD Billion)
- 8.4.7. India
- 8.4.7.1. India Oncology Biosimilar Market revenue, by Test Type, 2024 - 2032(USD Billion)
- 8.4.7.2. India Oncology Biosimilar Market revenue, by Drug Type, 2024 - 2032(USD Billion)
- 8.4.7.3. India Oncology Biosimilar Market revenue, by Distribution Channel , 2024 - 2032(USD Billion)
- 8.4.7.4. India Oncology Biosimilar Market revenue, by region, 2024 - 2032(USD Billion)
- 8.4.8. Rest of Asia Pacific
- 8.4.8.1. Rest of Asia Pacific Oncology Biosimilar Market revenue, by Test Type, 2024 - 2032(USD Billion)
- 8.4.8.2. Rest of Asia Pacific Oncology Biosimilar Market revenue, by Drug Type, 2024 - 2032(USD Billion)
- 8.4.8.3. Rest of Asia Pacific Oncology Biosimilar Market revenue, by Distribution Channel , 2024 - 2032(USD Billion)
- 8.4.8.4. Rest of Asia Pacific Oncology Biosimilar Market revenue, by region, 2024 - 2032(USD Billion)
- 8.5. Latin America
- 8.5.1. Latin America Oncology Biosimilar Market revenue, by Test Type, 2024 - 2032(USD Billion)
- 8.5.2. Latin America Oncology Biosimilar Market revenue, by Drug Type, 2024 - 2032(USD Billion)
- 8.5.3. Latin America Oncology Biosimilar Market revenue, by Distribution Channel , 2024 - 2032(USD Billion)
- 8.5.4. Latin America Oncology Biosimilar Market revenue, by Region, 2024 - 2032(USD Billion)
- 8.5.5. Brazil
- 8.5.5.1. Brazil Oncology Biosimilar Market revenue, by Test Type, 2024 - 2032(USD Billion)
- 8.5.5.2. Brazil Oncology Biosimilar Market revenue, by Drug Type, 2024 - 2032(USD Billion)
- 8.5.5.3. Brazil Oncology Biosimilar Market revenue, by Distribution Channel , 2024 - 2032(USD Billion)
- 8.5.5.4. Brazil Oncology Biosimilar Market revenue, by Region, 2024 - 2032(USD Billion)
- 8.5.6. Rest of Latin America
- 8.5.6.1. Rest of Latin America Oncology Biosimilar Market revenue, by Test Type, 2024 - 2032(USD Billion)
- 8.5.6.2. Rest of Latin America Oncology Biosimilar Market revenue, by Drug Type, 2024 - 2032(USD Billion)
- 8.5.6.3. Rest of Latin America Oncology Biosimilar Market revenue, by Distribution Channel , 2024 - 2032(USD Billion)
- 8.5.6.4. Rest of Latin America Oncology Biosimilar Market revenue, by Region, 2024 - 2032(USD Billion)
- 8.6. Middle East and Africa
- 8.6.1. Middle East and Africa Oncology Biosimilar Market revenue, by Test Type, 2024 - 2032(USD Billion)
- 8.6.2. Middle East and Africa Oncology Biosimilar Market revenue, by Drug Type, 2024 - 2032(USD Billion)
- 8.6.3. Middle East and Africa Oncology Biosimilar Market revenue, by Distribution Channel , 2024 - 2032(USD Billion)
- 8.6.4. Middle East and Africa Oncology Biosimilar Market revenue, by Region, 2024 - 2032(USD Billion)
- 8.1. Global Oncology Biosimilar Market: Regional overview
- Chapter 9. Company Profile
- 9.1. Teva Pharmaceutical Industries Ltd.
- 9.1.1. Overview
- 9.1.2. Financials
- 9.1.3. Therapy portfolio
- 9.1.4. Business strategy
- 9.1.5. Recent developments
- 9.2. Biocon
- 9.2.1. Overview
- 9.2.2. Financials
- 9.2.3. Therapy portfolio
- 9.2.4. Business strategy
- 9.2.5. Recent developments
- 9.3. STADA Arzneimittel AG
- 9.3.1. Overview
- 9.3.2. Financials
- 9.3.3. Therapy portfolio
- 9.3.4. Business strategy
- 9.3.5. Recent developments
- 9.4. Sandoz International GmbH
- 9.4.1. Overview
- 9.4.2. Financials
- 9.4.3. Therapy portfolio
- 9.4.4. Business strategy
- 9.4.5. Recent developments
- 9.5. Intas Pharmaceuticals Ltd.
- 9.5.1. Overview
- 9.5.2. Financials
- 9.5.3. Therapy portfolio
- 9.5.4. Business strategy
- 9.5.5. Recent developments
- 9.6. Celltrion Inc.
- 9.6.1. Overview
- 9.6.2. Financials
- 9.6.3. Therapy portfolio
- 9.6.4. Business strategy
- 9.6.5. Recent developments
- 9.1. Teva Pharmaceutical Industries Ltd.
Table Of Figures
List of Figures
1. Market research process
2. Market research methodology
3. Global Oncology Biosimilar Market revenue, 2024 – 2032 (USD Billion)
4. Porter’s five forces analysis
5. Oncology Biosimilar Market attractiveness analysis, by Test Type segment
6. Oncology Biosimilar Market attractiveness analysis, by Drug Type segment
7. Oncology Biosimilar Market attractiveness analysis, by Distribution Channel segment
8. Oncology Biosimilar Market: Market attractiveness analysis, by regional segment
9. Company market share analysis, 2024
10. Global Oncology Biosimilar Market revenue share by Test Type, 2024 and 2032
11. Global Oncology Biosimilar Market, 2024 – 2032 (USD Billion)
a. Global Breast Cancer market, 2024 – 2032(USD Billion)
b. Global Colorectal Cancer market, 2024 – 2032 (USD Billion)
c. Global Blood Cancer market, 2024 – 2032 (USD Billion)
d. Global Neutropenia Cancer market, 2024 – 2032(USD Billion)
e. Global Non-Small Cell Lung Cancer market, 2024 – 2032 (USD Billion)
f. Global Others market, 2024 – 2032 (USD Billion)
12. Global Oncology Biosimilar Market revenue share by Drug Type, 2024 and 2032
13. Global Oncology Biosimilar Market, 2024 – 2032 (USD Billion)
a. Global mAb market, 2024 – 2032(USD Billion)
b. Global Immunomodulators market, 2024 – 2032 (USD Billion)
c. Global Hematopoietic Agents market, 2024 – 2032 (USD Billion)
d. The global G-CSF market, 2024 – 2032 (USD Billion)
e. Global Others market, 2024 – 2032 (USD Billion)
14. Global Oncology Biosimilar Market revenue share by Distribution Channel , 2014 and 2022
15. Global Oncology Biosimilar Market, 2024 – 2032 (USD Billion)
a. Retail Pharmacies, 2024 – 2032 (USD Billion)
b. Hospital Pharmacy, 2024 – 2032 (USD Billion)
c. Online Pharmacy, 2024 – 2032 (USD Billion)
Table Of Tables
List of Tables
1. Oncology Biosimilar Market: Market snapshot
2. Drivers of global Oncology Biosimilar Market: Impact analysis
3. Restraints of Oncology Biosimilar Market: Impact analysis
4. North America Oncology Biosimilar Market revenue, by Test Type, 2024 – 2032 (USD Billion)
5. North America Oncology Biosimilar Market revenue, by Drug Type, 2024 – 2032 (USD Billion)
6. North America Oncology Biosimilar Market revenue, by Distribution Channel, 2024 – 2032 (USD Billion)
7. North America Oncology Biosimilar Market revenue, by Region, 2024 – 2032 (USD Billion)
8. U.S. Oncology Biosimilar Market revenue, by Test Type, 2024 – 2032 (USD Billion)
9. U.S. Oncology Biosimilar Market revenue, by Drug Type, 2024 – 2032 (USD Billion)
10. U.S. Oncology Biosimilar Market revenue, by Distribution Channel, 2024 – 2032 (USD Billion)
11. U.S. Oncology Biosimilar Market revenue, by Region, 2024 – 2032(USD Billion)
12. Rest of North America Oncology Biosimilar Market revenue, by Test Type, 2024 – 2032 (USD Billion)
13. Rest of North America Oncology Biosimilar Market revenue, by Drug Type, 2024 – 2032 (USD Billion)
14. Rest of North America Oncology Biosimilar Market revenue, by Distribution Channel, 2024 – 2032 (USD Billion)
15. Rest of North America Oncology Biosimilar Market revenue, by Region, 2024 – 2032 (USD Billion)
16. Europe Oncology Biosimilar Market revenue, by Test Type, 2024 – 2032 (USD Billion)
17. Europe Oncology Biosimilar Market revenue, by Drug Type, 2024 – 2032(USD Billion)
18. Europe Oncology Biosimilar Market revenue, by Distribution Channel, 2024 – 2032 (USD Billion)
19. Europe Oncology Biosimilar Market revenue, by Region, 2024 – 2032 (USD Billion)
20. Germany Oncology Biosimilar Market revenue, by Test Type, 2024 – 2032 (USD Billion)
21. Germany Oncology Biosimilar Market revenue, by Drug Type, 2024 – 2032 (USD Billion)
22. Germany Oncology Biosimilar Market revenue, by Distribution Channel, 2024 – 2032 (USD Billion)
23. Germany Oncology Biosimilar Market revenue, by Region, 2024 – 2032 (USD Billion)
24. U.K. Oncology Biosimilar Market revenue, by Test Type, 2024 – 2032 (USD Billion)
25. U.K. Oncology Biosimilar Market revenue, by Drug Type, 2024 – 2032 (USD Billion)
26. U.K. Oncology Biosimilar Market revenue, by Distribution Channel, 2024 – 2032 (USD Billion)
27. U.K. Oncology Biosimilar Market revenue, by Region, 2024 – 2032 (USD Billion)
28. France Oncology Biosimilar Market revenue, by Test Type, 2024 – 2032 (USD Billion)
29. France Oncology Biosimilar Market revenue, by Drug Type, 2024 – 2032 (USD Billion)
30. France Oncology Biosimilar Market revenue, by Distribution Channel , 2024 – 2032(USD Billion)
31. France Oncology Biosimilar Market revenue, by Region, 2024 – 2032 (USD Billion)
32. Rest of Europe Oncology Biosimilar Market revenue, by Test Type, 2024 – 2032 (USD Billion)
33. Rest of Europe Oncology Biosimilar Market revenue, by Drug Type, 2024 – 2032 (USD Billion)
34. Rest of Europe Oncology Biosimilar Market revenue, by Distribution Channel, 2024 – 2032 (USD Billion)
35. Rest of Europe Oncology Biosimilar Market revenue, by Region, 2024 – 2032(USD Billion)
36. Asia Pacific Oncology Biosimilar Market revenue, by Test Type, 2024 – 2032 (USD Billion)
37. Asia Pacific Oncology Biosimilar Market revenue, by Drug Type, 2024 – 2032 (USD Billion)
38. Asia Pacific Oncology Biosimilar Market revenue, by Distribution Channel, 2024 – 2032 (USD Billion)
39. Asia Pacific Oncology Biosimilar Market revenue, by Region, 2024 – 2032 (USD Billion)
40. China Oncology Biosimilar Market revenue, by Test Type, 2024 – 2032 (USD Billion)
41. China Oncology Biosimilar Market revenue, by Drug Type, 2024 – 2032 (USD Billion)
42. China Oncology Biosimilar Market revenue, by Distribution Channel, 2024 – 2032 (USD Billion)
43. China Oncology Biosimilar Market revenue, by Region, 2024 – 2032 (USD Billion)
44. Japan Oncology Biosimilar Market revenue, by Test Type, 2024 – 2032 (USD Billion)
45. Japan Oncology Biosimilar Market revenue, by Drug Type, 2024 – 2032 (USD Billion)
46. Japan Oncology Biosimilar Market revenue, by Distribution Channel, 2024 – 2032 (USD Billion)
47. Japan Oncology Biosimilar Market revenue, by Region, 2024 – 2032 (USD Billion)
48. India Oncology Biosimilar Market revenue, by Test Type, 2024 – 2032 (USD Billion)
49. India Oncology Biosimilar Market revenue, by Drug Type, 2024 – 2032 (USD Billion)
50. India Oncology Biosimilar Market revenue, by Distribution Channel, 2024 – 2032 (USD Billion)
51. India Oncology Biosimilar Market revenue, by region, 2024 – 2032 (USD Billion)
52. Rest of Asia Pacific Oncology Biosimilar Market revenue, by Test Type, 2024 – 2032 (USD Billion)
53. Rest of Asia Pacific Oncology Biosimilar Market revenue, by Drug Type, 2024 – 2032 (USD Billion)
54. Rest of Asia Pacific Oncology Biosimilar Market revenue, by Distribution Channel , 2024 – 2032(USD Billion)
55. Rest of Asia Pacific Oncology Biosimilar Market revenue, by Region, 2024 – 2032(USD Billion)
56. Latin America Oncology Biosimilar Market revenue, by Test Type, 2024 – 2032 (USD Billion)
57. Latin America Oncology Biosimilar Market revenue, by Drug Type, 2024 – 2032 (USD Billion)
58. Latin America Oncology Biosimilar Market revenue, by Distribution Channel, 2024 – 2032 (USD Billion)
59. Latin America Oncology Biosimilar Market revenue, by Region, 2024 – 2032 (USD Billion)
60. Brazil Oncology Biosimilar Market revenue, by Test Type, 2024 – 2032 (USD Billion)
61. Brazil Oncology Biosimilar Market revenue, by Drug Type, 2024 – 2032 (USD Billion)
62. Brazil Oncology Biosimilar Market revenue, by Distribution Channel, 2024 – 2032 (USD Billion)
63. Brazil Oncology Biosimilar Market revenue, by Region, 2024 – 2032 (USD Billion)
64. Rest of Latin America Oncology Biosimilar Market revenue, by Test Type, 2024 – 2032 (USD Billion)
65. Rest of Latin America Oncology Biosimilar Market revenue, by Drug Type, 2024 – 2032 (USD Billion)
66. Rest of Latin America Oncology Biosimilar Market revenue, by Distribution Channel, 2024 – 2032 (USD Billion)
67. Rest of Latin America Oncology Biosimilar Market revenue, by Region, 2024 – 2032 (USD Billion)
68. The Middle East and Africa Oncology Biosimilar Market revenue, by Test Type, 2024 – 2032 (USD Billion)
69. The Middle East and Africa Oncology Biosimilar Market revenue, by Drug Type, 2024 – 2032 (USD Billion)
70. The Middle East and Africa Oncology Biosimilar Market revenue, by Distribution Channel, 2024 – 2032 (USD Billion)
71. The Middle East and Africa Oncology Biosimilar Market revenue, by Region, 2024 – 2032 (USD Billion)
Methodology
FrequentlyAsked Questions
An oncology biosimilar is a biological product that is highly similar to an already approved reference biologic drug used in the treatment of cancer.
According to study, the global oncology biosimilar market size was worth around USD 6.13 billion in 2023 and is predicted to grow to around USD 28.26 billion by 2032.
The CAGR value of oncology biosimilar market is expected to be around 18.50% during 2024-2032.
North America has been leading the global oncology biosimilar market and is anticipated to continue on the dominant position in the years to come.
The global oncology biosimilar market is led by players like Teva Pharmaceutical Industries Ltd., Biocon, STADA Arzneimittel AG, Sandoz International GmbH, Intas Pharmaceuticals Ltd., Celltrion Inc., Pfizer Inc., Apotex Inc., Dr. Reddy’s Laboratories Ltd., BIOCAD, and among others.
RelatedNews
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed